Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct;36(10):1910-21.
doi: 10.1007/s11064-011-0513-3. Epub 2011 Jun 1.

Activation of Liver X Receptor Decreases BACE1 Expression and Activity by Reducing Membrane Cholesterol Levels

Affiliations

Activation of Liver X Receptor Decreases BACE1 Expression and Activity by Reducing Membrane Cholesterol Levels

Weigang Cui et al. Neurochem Res. .

Abstract

The synthetic Liver X receptor (LXR) activator T0901317 has been reported to exert neuroprotective effect in Alzheimer's disease, but the relationship between LXR activation and beta-site amyloid precursor protein cleaving enzyme 1 (BACE-1) remains uncertain. This study investigated the effect of T0901317 on membrane cholesterol levels, BACE1 expression and activity. We found that T0901317 decreased membrane cholesterol levels, reduced BACE1 expression and activity as well as β-secretase cleaved C-terminal fragment (β-CTF) levels in vivo and in vitro. Meanwhile, the expression of ATP-binding membrane cassette transport protein A1 (ABCA1) enhanced. Additionally, inhibition of ABCA1 abrogated the effects of T0901317 on membrane cholesterol levels and β-secretase activity. Moreover, addition of LXR antagonist reversed the effect of T0901317 on ABCA1 mRNA expression, membrane cholesterol levels and β-secretase activity. Our results suggest that activation of LXR may decrease BACE1 expression and activity through a pathway associated with ABCA1-mediated reduction in membrane cholesterol levels.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

References

    1. Mol Cell Neurosci. 2010 Dec;45(4):408-17 - PubMed
    1. Neurobiol Dis. 2009 Mar;33(3):482-98 - PubMed
    1. J Biol Chem. 2005 Feb 11;280(6):4079-88 - PubMed
    1. J Biol Chem. 2001 Jun 29;276(26):23742-7 - PubMed
    1. Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1178-84 - PubMed

MeSH terms

LinkOut - more resources

Feedback